Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding

OBJECTIVE: To compare the effect of a levonorgestrel-releasing intrauterine device with that of endometrial resection on menstrual bleeding, patient satisfaction, and quality of life in menorrhagic women during 12 months of follow-up. METHODS: Seventy premenopausal women with dysfunctional uterine bleeding were enrolled in a prospective, open, parallel-group, controlled trial. They were randomized to either insertion of an intrauterine system releasing 20 micrograms/day of levonorgestrel (n = 35) or endometrial resection (n = 35). The women were evaluated at baseline, and thereafter, uterine bleeding was assessed monthly with a pictorial blood loss assessment chart. Clinical gynecologic examination was performed bimonthly, and the hematologic variables were measured at 6 and 12 months. On the latter occasion, the women were requested to rate the degree of satisfaction with the effect of their treatment and to complete the Short Form 36 General Health Survey questionnaire. RESULTS: Recurrent menorrhagia was observed at 12 months in four women in the intrauterine device group (including two with partial expulsion of the device) and in three women in the resection group. Compared with baseline values, at 1 year, the pictorial blood loss assessment chart score was reduced by 79% in the former group and by 89% in the latter. Amenorrhea or hypomenorrhea at 12 months was reported by 65% of the women with an intrauterine device compared with 71% who underwent endometrial resection. The degree of satisfaction with treatment was high in both groups, with 29 of 34 (85%) women being satisfied or very satisfied in the intrauterine device group versus 33 of 35 (94%) in the resection group. Health-related quality of life perception was not significantly different in the two treatment groups. CONCLUSION: Somewhat less satisfactory results were obtained with a levonorgestrel-releasing intrauterine system compared with endometrial resection for dysfunctional uterine bleeding at 1 year of follow-up.

This article has been cited by other articles:

				R. K. Hejmadi, S. Chaudhri, R. Ganesan, and T. P. Rollason Morphologic Changes in the Endometrium Associated With the Use of the Mirena Coil: A Retrospective Study of 106 Cases International Journal of Surgical Pathology, April 1, 2007; 15(2): 148 - 154. [Abstract] [PDF]

				H. T. Sharp Assessment of new technology in the treatment of idiopathic menorrhagia and uterine leiomyomata. Obstet. Gynecol., October 1, 2006; 108(4): 990 - 1003. [Abstract] [Full Text] [PDF]

				J. H.S. You, D. S. Sahota, and P. MoYuen A cost-utility analysis of hysterectomy, endometrial resection and ablation and medical therapy for menorrhagia Hum. Reprod., July 1, 2006; 21(7): 1878 - 1883. [Abstract] [Full Text] [PDF]

				I. Rauramo, I. Elo, and O. Istre Long-Term Treatment of Menorrhagia With Levonorgestrel Intrauterine System Versus Endometrial Resection Obstet. Gynecol., December 1, 2004; 104(6): 1314 - 1321. [Abstract] [Full Text] [PDF]

				R. Hurskainen, J. Teperi, P. Rissanen, A.-M. Aalto, S. Grenman, A. Kivela, E. Kujansuu, S. Vuorma, M. Yliskoski, and J. Paavonen Clinical Outcomes and Costs With the Levonorgestrel-Releasing Intrauterine System or Hysterectomy for Treatment of Menorrhagia: Randomized Trial 5-Year Follow-up JAMA, March 24, 2004; 291(12): 1456 - 1463. [Abstract] [Full Text] [PDF]

				C.D.d. Kroon, J.C.v. Houwelingen, J.B. Trimbos, and F.W. Jansen The value of transvaginal ultrasound to monitor the position of an intrauterine device after insertion. A technology assessment study Hum. Reprod., November 1, 2003; 18(11): 2323 - 2327. [Abstract] [Full Text] [PDF]

				Levonorgestrel intra-uterine system for menorrhagia DTB, November 1, 2001; 39(11): 85 - 87. [Abstract] [Full Text] [PDF]

				T. Maruo, J.B. Laoag-Fernandez, P. Pakarinen, H. Murakoshi, I.M. Spitz, and E. Johansson Effects of the levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometrium Hum. Reprod., October 1, 2001; 16(10): 2103 - 2108. [Abstract] [Full Text] [PDF]

				S. Brechin, S.T. Cameron, A.M. Paterson, A.R. Williams, and H.O.D. Critchley Intrauterine polyps--a cause of unscheduled bleeding in women using the levonorgestrel intrauterine system: Case Report Hum. Reprod., March 1, 2000; 15(3): 650 - 652. [Abstract] [Full Text] [PDF]

				A. Prentice Fortnightly review: Medical management of menorrhagia BMJ, November 20, 1999; 319(7221): 1343 - 1345. [Full Text]

				P. VERCELLINI, S. OLDANI, L. YAYLAYAN, B. ZAINA, O. DE GIORGI, and P. G. CROSIGNANI Randomized Comparison of Vaporizing Electrode and Cutting Loop for Endometrial Ablation Obstet. Gynecol., October 1, 1999; 94(4): 521 - 527. [Abstract] [Full Text] [PDF]

				C. Kelleher and P. Braude Recent advances: Gynaecology BMJ, September 11, 1999; 319(7211): 689 - 692. [Full Text]

				A. Ikomi and N. Gupta Randomised controlled trial exists of levonorgestrel intrauterine system for menorrhagia BMJ, October 31, 1998; 317(7167): 1250 - 1250. [Full Text]